恩晶生物-产品-Cediranib (AZD2171)

Catalog Number:
E1KS1017
Amount:
5mg
Storage/Stability:
at -20℃ 2 years
References:
AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer Stephen R. Wedge, Jane Kendrew,et al. Cancer Res 2005;65:4389-4400 Design and Structure-Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors Laurent F. Hennequin,Andrew P. Thomas,et al. J. Med. Chem 1999;42:5369-5389 ZD6474 Inhibits Vascular Endothelial Growth Factor Signaling,Angiogenesis, and Tumor Growth following Oral Administration Donald J. Ogilvie, Michael Dukes, et al. Cancer Res 2006;62:4645-4655 AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer Jane Kendrew, Laurent F. Hennequin, et al. Cancer Res 2005;65:4389-4400 The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.